PUBLISHER: The Business Research Company | PRODUCT CODE: 1753866
PUBLISHER: The Business Research Company | PRODUCT CODE: 1753866
House dust mite allergy, also known as dust mite allergy or dust allergy, is an allergic reaction triggered by the proteins found in the feces, body parts and secretions of dust mites. Dust mites are microscopic arthropods that thrive in indoor environments, particularly in warm, humid conditions. They are commonly found in bedding, upholstered furniture, carpets, curtains and other soft furnishings where they feed on dead skin cells shed by humans and pets.
The house dust mite allergy market consists of sales, by entities (organizations, sole traders and partnerships), of house dust mite allergy treatment products designed to either reduce exposure to allergens or to treat the symptoms and underlying immune response.
The global house dust mite allergy market was valued at $1,354.10 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 9.00%.
Rising Healthcare Expenditures
During the historic period, the rising healthcare expenditures supported the growth of the house dust mite allergy market. As healthcare spending rises, both public and private sectors increasingly allocate resources toward the diagnosis and management of chronic, non-life-threatening conditions such as allergies. With more funding, diagnostic tools such as skin prick and serum immunoglobulin E tests (IgE) are more widely used, leading to better identification of triggers like house dust mites (HDM) and earlier initiation of treatment. The growth in spending also supports the expansion of allergy and immunology specialists into both urban and semi-urban areas. For instance, in January 2024, according to national health expenditures accounts (NHEA) by KFF, a US-based independent source for health policy research, polling and journalism, health spending in the USA was increased by 5% from 2023 to 2024, reaching $4.9 trillion. Additionally, in May 2023, the UK's Office for National Statistics, a government agency, released a report stating that between 2020 and 2021, healthcare spending in the UK increased by 9.4% nominally and 9.7% practically. The total cost of healthcare in the UK in 2021 was $367.25 billion (£280.7 billion), pharmaceutical costs were $51.84 billion (£39.6 billion) and spending on preventative care increased significantly from 2020 to 2021, reaching $45.93 billion (£35.1 billion). Therefore, the rising healthcare expenditures drove the growth of the house dust mite allergy market.
Strategic Partnerships Driving The Evolution Of Immunotherapy In Allergy Care
Major companies operating in the house dust mite allergy market are adopting strategic partnerships approach to develop advanced solutions. Strategic partnerships help house dust mite allergy companies by combining resources and expertise, enhancing research and development capabilities, expanding market reach and accelerating commercialization, ultimately driving innovation and growth in the house dust mite allergy industry. For instance, in February 2025, ALK, a Denmark-based pharmaceutical company, partnered with Torii Pharmaceutical, a Japan-based pharmaceutical company, that offers house dust mite allergy tablets by granting exclusive rights to develop, market and distribute its allergy immunotherapy tablet for grass pollen allergy in Japan. This agreement builds on their existing collaboration, which already covers cedar pollen and house dust mite (HDM) allergy treatments. Torii Pharmaceutical offers sublingual immunotherapy tablets for HDM allergy under the brand MITICURE, approved for both adults and children. The expanded partnership reinforces Torii's position in the Japanese allergy treatment market and broadens its portfolio of allergen-specific therapies.
The global house dust mite allergy markets are concentrated, with large players operating in the market. The top 10 competitors in the market made up 46.17% of the total market in 2023.
House Dust Mite Allergy Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global house dust mite allergy market as it emerges from the COVID-19 shut down.
Where is the largest and fastest-growing market for house dust mite allergy? how does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The house dust mite allergy market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider house dust mite allergy market; and compares it with other markets.